Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
New research has reinforced the efficacy of Cingulate's Precision Timed Release™ (PTR™) platform and its three-pronged drug delivery system. The study underscores the platform's effectiveness in delivering medication with precision timing. This validation adds to the growing body of evidence supporting PTR™, which has demonstrated remarkable outcomes in drug delivery. The findings highlight the platform's potential to enhance the targeted release of medications, offering a promising solution for optimized treatment.
